Metric Analysis: Zymeworks BC Inc (ZYME)’s Key Ratios in the Limelight

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

In the latest session, Zymeworks BC Inc (NASDAQ: ZYME) closed at $11.74 down -8.64% from its previous closing price of $12.85. In other words, the price has decreased by -$8.64 from its previous closing price. On the day, 0.55 million shares were traded.

Ratios:

For a deeper understanding of Zymeworks BC Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.40 and its Current Ratio is at 3.40. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.

On November 07, 2024, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $10 to $25.

Wells Fargo Downgraded its Overweight to Equal Weight on November 01, 2024, while the target price for the stock was maintained at $12.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 16 ’25 when EcoR1 Capital, LLC bought 73,953 shares for $11.16 per share. The transaction valued at 825,589 led to the insider holds 17,773,727 shares of the business.

EcoR1 Capital, LLC bought 54,760 shares of ZYME for $630,819 on Apr 17 ’25. The Director now owns 17,828,487 shares after completing the transaction at $11.52 per share. On Apr 04 ’25, another insider, EcoR1 Capital, LLC, who serves as the Director of the company, bought 196,438 shares for $11.17 each. As a result, the insider paid 2,193,800 and bolstered with 17,699,774 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 10.79 while its Price-to-Book (P/B) ratio in mrq is 2.41.

Stock Price History:

Over the past 52 weeks, ZYME has reached a high of $17.70, while it has fallen to a 52-week low of $8.21. The 50-Day Moving Average of the stock is -3.30%, while the 200-Day Moving Average is calculated to be -8.98%.

Shares Statistics:

A total of 68.96M shares are outstanding, with a floating share count of 67.30M. Insiders hold about 4.07% of the company’s shares, while institutions hold 97.88% stake in the company.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.